WEBINAR VIDEO | The New EU Deforestation Regulation: Stay Compliant, Succeed Sustainably

WEBINAR VIDEO | The New EU Deforestation Regulation: Stay Compliant, Succeed Sustainably
July 3, 2023

In this Life Sciences session, the experts from our agri-food law team Philippe de Jong and Bart Junior Bollen provided valuable insights into the Regulation’s implications and equiped businesses with the necessary knowledge to ensure compliance in this evolving landscape. you

Contact

  • Philippe de Jong

    Partner

  • Bart Junior Bollen

    Associate

Recommended articles

November 07, 2025

Belgian Constitutional Court strikes down pharma industry ‘unavailability contribution’

The Belgian Constitutional Court (“CC”), on 6 November 2025, annulled some provisions of the Law of 18 May 2024 containing various provisions on health and finance, striking down the pharma industry ‘unavailability contribution’. Background Parts of the above Law sought to protect patients from bearing additional costs when reimbursable medicines become unavailable and must be […]

Read on
October 09, 2025

Food Hygiene for Fish: EU General Court Requires Scientific Basis to “Clarify” the Law

Food company Mowi Poland successfully challenged the European Commission’s new hygiene rules governing ‘stiffening’—a specialised fish processing technique—on the grounds that the Commission failed to obtain mandatory scientific consultation. While the Commission defended its approach by characterising the measures as mere “clarification” of existing law and citing industry guidelines as support, the EU General Court […]

Read on
September 17, 2025

Combination therapies in Belgium: how to collaborate without breaching competition law

As the landscape of modern medicine evolves, combination therapies—those that use two or more distinct medicines, often from different companies—are becoming increasingly vital, especially in treating complex diseases like cancer. These therapies promise improved clinical outcomes through synergistic mechanisms of action. However, the reimbursement process for such therapies presents significant regulatory and legal challenges, particularly […]

Read on